Cassidy received commitments from the nation’s health secretary in return for Cassidy’s support, but those promises are ...

Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.

The ouster of Peter Marks, the FDA official who oversaw vaccines, gene therapies, and the blood supply, has alarmed biopharma ...

Pluvicto, Novartis’ blockbuster radiopharmaceutical for prostate cancer, has been greenlighted by the FDA for use earlier in ...

I]t has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient ...

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

What will be lost when medical students are no longer made to uncomfortably face death to learn from what a real human body ...

DOJ takes a new approach on Medicaid fraud, a revamped lawsuit against UnitedHealth, and more health care news.

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the ...

WASHINGTON — The House’s plan to cut government spending, including on Medicaid, to help pay for the extension of tax cuts is already hitting snags. The House budget resolution, which sets ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...